Citation: E. Hunter et al., FUNCTIONAL PARTITIONING OF ENERGY RESERVES BY LARVAE OF THE MARINE BRYOZOAN BUGULA-NERITINA (L.), Journal of Experimental Biology, 201(20), 1998, pp. 2857-2865
Authors:
YOTSUKURA M
FUJII K
KATAYAMA A
TOMONO Y
ANDO H
SAKATA K
ISHIHARA T
ISHIKAWA K
Citation: M. Yotsukura et al., 9-YEAR FOLLOW-UP-STUDY OF HEART-RATE-VARIABILITY IN PATIENTS WITH DUCHENNE-TYPE PROGRESSIVE MUSCULAR-DYSTROPHY, The American heart journal, 136(2), 1998, pp. 289-296
Authors:
YOTSUKURA M
KOIDE Y
FUJII K
TOMONO Y
KATAYAMA A
ANDO H
SUZUKI J
ISHIKAWA K
Citation: M. Yotsukura et al., HEART-RATE-VARIABILITY DURING THE FIRST MONTH OF SMOKING CESSATION, The American heart journal, 135(6), 1998, pp. 1004-1009
Authors:
YOTSUKURA M
TOMONO Y
YAMAGUCHI T
TAYA M
SUZUKI J
TAMURA T
ISHIHARA T
ISHIKAWA K
Citation: M. Yotsukura et al., QT DISPERSION AND VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH PROGRESSIVE MUSCULAR-DYSTROPHY OF THE DUCHENNE TYPE, Journal of the American College of Cardiology, 29(2), 1997, pp. 56166-56166
Authors:
BAE MA
YAMADA K
IJUIN Y
TSUJI T
YAZAWA K
TOMONO Y
UEMURA D
Citation: Ma. Bae et al., ABURATUBOLACTAM-A, A NOVEL INHIBITOR OF SUPEROXIDE ANION GENERATION FROM A MARINE MICROORGANISM, Heterocyclic communications, 2(4), 1996, pp. 315-318
Citation: H. Hirota et al., TERPENOIDS WITH ANTIFOULING ACTIVITY AGAINST BARNACLE LARVAE FROM THEMARINE SPONGE ACANTHELLA-CAVERNOSA, Tetrahedron, 52(7), 1996, pp. 2359-2368
Authors:
UEMATSU T
NAGASHIMA S
NIWA M
KOHNO K
SASSA T
ISHII M
TOMONO Y
YAMATO C
KANAMARU M
Citation: T. Uematsu et al., EFFECT OF DIETARY-FAT CONTENT ON ORAL BIOAVAILABILITY OF MENATETRENONE IN HUMANS, Journal of pharmaceutical sciences, 85(9), 1996, pp. 1012-1016
Authors:
TAKAI Y
OGAWARA M
TOMONO Y
MORITOH C
IMAJOHOHMI S
TSUTSUMI O
TAKETANI Y
INAGAKI M
Citation: Y. Takai et al., MITOSIS-SPECIFIC PHOSPHORYLATION OF VIMENTIN BY PROTEIN-KINASE-C COUPLED WITH REORGANIZATION OF INTRACELLULAR MEMBRANES, The Journal of cell biology, 133(1), 1996, pp. 141-149
Citation: S. Usui et al., PREPARATION AND ANTITUMOR ACTIVITIES OF BETA-(1-]6) BRANCHED (1-]3)-BETA-D-GLUCAN DERIVATIVES, Biological & pharmaceutical bulletin, 18(12), 1995, pp. 1630-1636
Citation: Y. Tomono et al., FATTY-ACID COMPOSITION OF GANGLIOSIDE GM3 OF RENAL GLOMERULAR EPITHELIAL SGE1 CELLS DURING SPONTANEOUS DOME FORMATION IN-VITRO, Cell structure and function, 20(4), 1995, pp. 269-274
Authors:
YASUDA S
HORAI Y
TOMONO Y
NAKAI H
YAMATO C
MANABE K
KOBAYASHI K
CHIBA K
ISHIZAKI T
Citation: S. Yasuda et al., COMPARISON OF THE KINETIC DISPOSITION AND METABOLISM OF E3810, A NEW PROTON PUMP INHIBITOR, AND OMEPRAZOLE IN RELATION TO S-MEPHENYTOIN 4'-HYDROXYLATION STATUS, Clinical pharmacology and therapeutics, 58(2), 1995, pp. 143-154
Authors:
ISHIZAKI T
CHIBA K
MANABE K
KOYAMA E
HAYASHI M
YASUDA S
HORAI Y
TOMONO Y
YAMATO C
TOYOKI T
Citation: T. Ishizaki et al., COMPARISON OF THE INTERACTION POTENTIAL OF A NEW PROTON PUMP INHIBITOR, E3810, VERSUS OMEPRAZOLE WITH DIAZEPAM IN EXTENSIVE AND POOR METABOLIZERS OF S-MEPHENYTOIN 4'-HYDROXYLATION, Clinical pharmacology and therapeutics, 58(2), 1995, pp. 155-164
Authors:
YASUDA S
OHNISHI A
OGAWA T
TOMONO Y
HASEGAWA J
NAKAI H
SHIMAMURA Y
MORISHITA N
Citation: S. Yasuda et al., PHARMACOKINETIC PROPERTIES OF E3810, A NEW PROTON PUMP INHIBITOR, IN HEALTHY MALE-VOLUNTEERS, International journal of clinical pharmacology and therapeutics, 32(9), 1994, pp. 466-473
Authors:
NAKASHIMA M
UEMATSU T
NAGASHIMA S
INABA H
HIRASAWA T
TOMONO Y
OHNO T
OKANO K
MORISHITA N
Citation: M. Nakashima et al., PHASE-I STUDY OF E1077, A NOVEL PARENTERAL CEPHEM ANTIBIOTIC, Journal of clinical pharmacology, 34(11), 1994, pp. 1053-1059
Authors:
OHNISHI A
MIHARA M
YASUDA S
TOMONO Y
HASEGAWA J
TANAKA T
Citation: A. Ohnishi et al., AQUARETIC EFFECT OF THE STABLE DYNORPHIN-A ANALOG E2078 IN THE HUMAN, The Journal of pharmacology and experimental therapeutics, 270(1), 1994, pp. 342-347
Authors:
ISHIZAKI T
CHIBA K
MANABE K
KOYAMA E
YASUDA S
HORAI Y
TOMONO Y
YAMATO S
Citation: T. Ishizaki et al., COMPARISON OF THE EFFECTS OF E3810 AND OMEPRAZOLE ON DIAZEPAM PHARMACOKINETICS IN EXTENSIVE AND POOR METABOLIZERS OF S-MEPHENYTOIN, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 141-141
Authors:
YASUDA S
HORAI Y
TOMONO Y
NAKAI H
YAMATO C
MANABE K
KOBAYASHI K
CHIBA K
ISHIZAKI T
Citation: S. Yasuda et al., PHARMACOKINETICS OF E3810 AND OMEPRAZOLE IN RELATION TO POLYMORPHIC HYDROXYLATION OF S-MEPHENYTOIN, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 165-165
Authors:
MIHARA M
OHNISHI A
TOMONO Y
HASEGAWA J
SHIMAMURA Y
YAMAZAKI K
MORISHITA N
Citation: M. Mihara et al., PHARMACOKINETICS OF E2020, A NEW COMPOUND FOR ALZHEIMERS-DISEASE, IN HEALTHY MALE-VOLUNTEERS, International journal of clinical pharmacology, therapy and toxicology, 31(5), 1993, pp. 223-229
Citation: N. Morishita et Y. Tomono, STUDY OF THE PHARMACOKINETIC DOSE-LINEARITY OF A SUSTAINED-RELEASE FORMULATION OF BUNAZOSIN (E1015) IN HEALTHY-VOLUNTEERS, Drug investigation, 6(2), 1993, pp. 57-61
Authors:
MORISHITA N
TOMONO Y
HASEGAWA J
BRANAGAN P
HOUSTON AC
WEBER W
HEUER HJ
PABST G
Citation: N. Morishita et al., SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS OF A SUSTAINED-RELEASE FORMULATION OF BUNAZOSIN (E1015) IN HEALTHY-YOUNG AND ELDERLY VOLUNTEERS, Drug investigation, 6(2), 1993, pp. 62-69
Authors:
MORISHITA N
TOMONO Y
MAINGUY Y
BRANAGAN P
BROMETPETIT M
BROMET N
Citation: N. Morishita et al., A DOSE DUMPING STUDY WITH A SUSTAINED-RELEASE FORMULATION OF BUNAZOSIN (E1015) IN HEALTHY-VOLUNTEERS, Drug investigation, 6(1), 1993, pp. 1-4
Citation: N. Morishita et al., SINGLE-DOSE CROSSOVER STUDY TO EVALUATE THE ABSOLUTE BIOAVAILABILITY OF A SUSTAINED-RELEASE FORMULATION OF BUNAZOSIN (E1015) IN HEALTHY MALE-VOLUNTEERS, Drug investigation, 6(1), 1993, pp. 5-9